Showing results (111-120 of 302) with videos related to

Sort By:
Pageof 31
International Pharmacopsychiatry|January 1, 1980
Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical studyW M Petrie, J P McEvoy, W H Wilson, et al.
Schizophrenia Bulletin|January 1, 1996
Common sense, insight, and neuropsychological test performance in schizophrenia patientsJ P McEvoy, M Hartman, D Gottlieb, et al.
BMC Medical Education|December 1, 2011
Evidence-based practice profiles of physiotherapists transitioning into the workforce: a study of two cohortsMaureen P McEvoy, Marie T Williams, Timothy S Olds, et al.
Psychopharmacology|January 1, 1993
An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patientsJ P McEvoy, G Movin-Osswald, G Uppfeldt, et al.
Psychopharmacology|May 1, 1997
A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawalR F Anton, H R Kranzler, J P McEvoy, et al.
BMC Psychiatry|March 25, 2021
Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophreniaJoseph P McEvoy, Peter J Weiden, Paul H Lysaker, et al.
BMC Psychiatry|August 28, 2022
Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trialPaul H Lysaker, Peter J Weiden, Xiaowu Sun, et al.
Marine Pollution Bulletin|December 4, 2018
Ingestion of plastic by fish: A comparison of Thames Estuary and Firth of Clyde populationsAlexandra R McGoran, Phillip R Cowie, Paul F Clark, et al.
Comprehensive Psychiatry|January 1, 1989
Why must some schizophrenic patients be involuntarily committed? The role of insightJ P McEvoy, P S Applebaum, L J Apperson, et al.
Psychiatry Research|February 17, 1998
Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illnessJ H Gilmore, L F Jarskog, J C Lindgren, et al.
Pageof 31